WASHINGTON — House Oversight Chairman Elijah Cummings (Md.) isn’t the only newly empowered Democrat with his eyes on drug makers.
Rep. Diana DeGette of Colorado, the newly minted chair of the Energy and Commerce Committee’s oversight arm, is also planning to haul industry CEOs before her own panel, she said Wednesday at a briefing with reporters.
“Oh, yeah,” DeGette responded, when STAT asked if she planned to ask pharmaceutical companies to testify.
About the Author Reprints
I might subscribe if wasn’t for the tease of a gov’t oversight committee article, which last I looked you didn’t pay for on a free perhaps no longer open internet.
What you produce warrents renumeration but not this….Soooooo! WOT